Talk:2023 Project 6

References

1. Tang, Y., Durand, S., Dalle, S. & Caramel, J. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment. Cancers (Basel). 12, 1–17 (2020). PMID: 32759677

2. Vandamme, N. & Berx, G. From neural crest cells to melanocytes: cellular plasticity during development and beyond. Cell. Mol. Life Sci. 76, 1919–1934 (2019). PMID: 30830237

3. Adameyko, I. et al. Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139, 366–379 (2009). PMID: 19837037

4. Kaucka, M. et al. Nerve-associated Schwann cell precursors contribute extracutaneous melanocytes to the heart, inner ear, supraorbital locations and brain meninges. Cell. Mol. Life Sci. 78, 6033–6049 (2021). PMID: 34274976

5. Bonnamour, G., Soret, R. & Pilon, N. Dhh-expressing Schwann cell precursors contribute to skin and cochlear melanocytes, but not to vestibular melanocytes. Pigment Cell Melanoma Res. 34, 648–654 (2021). PMID: 33089656

6. Orlow, S. J. Melanosomes Are Specialized Members of the Lysosomal Lineage of Organelles. J. Invest. Dermatol. 105, 3–7 (1995). PMID: 7615972

7. Raposo, G. & Marks, M. S. Melanosomes — dark organelles enlighten endosomal membrane transport. Nat. Rev. Mol. Cell Biol. 2007 810 8, 786–797 (2007). PMID: 17878918

8. Cichorek, M., Wachulska, M., Stasiewicz, A. & Tymińska, A. Skin melanocytes: biology and development. Adv. Dermatology Allergol. Dermatologii i Alergol. 30, 30–41 (2013). PMID: 24278043 Review.

9. Arlo J Miller & Martin C Mihm Jr. Melanoma. N. Engl. J. Med. 355, 129–135 (2006). PMID: 16822996

10. Markovic, S. N. et al. Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis. Mayo Clin. Proc. 82, 364–380 (2007). PMID: 17352373

11. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012). PMID: 22817889

12. Balch, C. M. et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199–6206 (2009). PMID: 19917835

13. Pedri, D., Karras, P., Landeloos, E., Marine, J. C. & Rambow, F. Epithelial-to-mesenchymal-like transition events in melanoma. FEBS J. 289, 1352–1368 (2022). PMID: 33999497

14. Jaworek-Korjakowska, J. & Kleczek, P. ESkin: Study on the smartphone application for early detection of malignant melanoma. Wirel. Commun. Mob. Comput. 2018, (2018).

15. Borovansky, J., Mirejovsky, P. & Riley, P. A. Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma. Neoplasma 38, 393–400 (1991). PMID: 1922572

16. Lazova, R. & Pawelek, J. M. Why do melanomas get so dark? Exp. Dermatol. 18, 934–938 (2009). PMID: 19645853

17. Dror, S. et al. Melanoma miRNA trafficking controls tumour primary niche formation. Nat. Cell Biol. 2016 189 18, 1006–1017 (2016). PMID: 27548915

18. Singh, S. K. et al. The silver locus product (Silv/gp100/Pmel17) as a new tool for the analysis of melanosome transfer in human melanocyte-keratinocyte co-culture. Exp. Dermatol. 17, 418–426 (2008). PMID: 18331332

19. Kawakami, Y. et al. The use of melanosomal proteins in the immunotherapy of melanoma. J. Immunother. 21, 237–246 (1998). PMID: 9672845 Review.

20. Shain, A. H. & Bastian, B. C. From melanocytes to melanomas. Nat. Rev. Cancer 16, 345–358 (2016). PMID: 27125352 Review.

21. Shain, A. H. et al. The Genetic Evolution of Melanoma from Precursor Lesions. N. Engl. J. Med. 373, 1926–1936 (2015). PMID: 26559571

22. Rambow, F., Marine, J. C. & Goding, C. R. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev. 33, 1295–1318 (2019). PMID: 31575676

23. White, R. M. et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518–522 (2011).

24. Diener, J. & Sommer, L. Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment. Stem Cells Transl. Med. 10, 522–533 (2021). PMID: 33258291

25. Huang, F., Santinon, F., Flores González, R. E. & del Rincón, S. V. Melanoma plasticity: promoter of metastasis and resistance to therapy. Front. Oncol. 11, (2021). PMID: 34604096 Review.

26. Rosenbaum, S. R. et al. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects. Cell Rep. 37, 110085. (2021). PMID: 34879275

27. Abou-Hamad, J. et al. CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness. iScience 25, 105524 (2022). PMID: 36437876

28. Boiko, A. D. et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133–137 (2010). PMID: 20596026

29. Ngo, M. et al. Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts. Cell Rep. 16, 1701–1716 (2016). PMID: 27477289